New Drug, Pradaxa, May Prevent Second Stroke in Certain Hear... ( MONDAY Nov. 8 (Health...)

New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients

Date:11/8/2010

MONDAY, Nov. 8 (HealthDay News) -- Among certain patients with a history of stroke or mini-stroke, a new anticlotting medication called Pradaxa (dabigatran) appears to be as effective as the anticoagulant drug warfarin at preventing a second stroke, new German research reveals.

Specifically, the new study suggests that Pradaxa can reduce the risk of a second stroke as effectively as warfarin among those facing an elevated risk for stroke or arterial blood clot (systemic embolism) as a result of having atrial fibrillation, the most common form of abnormal heart rhythm (or cardiac arrhythmia).

What's more, depending on the dosage used, Pradaxa appeared to fare at least as well or better than warfarin in terms of limiting the risk for bleeding -- a known warfarin side effect.

Pradaxa was recently approved by the U.S. Food and Drug Administration -- at a dosage of 150 milligrams -- for the prevention of first stroke among atrial fibrillation patients.

The current effort took a look at the drug in two twice-daily dosages of either 110 mg or 150 mg among more than 3,600 atrial fibrillation patients, all of whom had previously experienced a stroke or a mini-stroke, also known as a transient ischemic attack.

All of the patients had participated in the larger Randomized Evaluation of Long-Term Anticoagulation Therapy study, which had included more than 18,000 people, 80 percent of whom had no prior history of stroke.

Last year, results of a prior analysis concerning this full study group indicated that at the lower dosage, Pradaxa was as effective at reducing stroke risk as warfarin, while the higher dosage provided even better stroke protection than warfarin.

The new study, published in the Nov. 8 online edition of The Lancet Neurology, was led by Dr. Hans-Christoph Diener from the department of neurology at University Hospital Essen in Essen, Germany.

Diener and his associates focused solely
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Researchers engineer microbes for low-cost production of anti-cancer drug, Taxol
2. Many Falls, and Resulting ER Visits, Can Be Prevented
3. Asthma drug prevents spread of breast cancer: study
4. Black raspberries may prevent colon cancer, study finds
5. Program May Help Prevent Falls in Hospitalized Patients
6. Pitt study finds NSAIDs cause stem cells to self-destruct, preventing colon cancer
7. Healthy Living Can Prevent Nearly 25% of Colorectal Cancers
8. Chemotherapy plus radiation prevents bladder cancer recurrences
9. Radiation Before Surgery May Prevent Return of Rectal Cancer
10. Wildlife health reporting tools may help prevent human illness
11. UCLA gets $4.6M grant to study HIV treatment, prevention among men from L.A. jails

Post Your Comments:

Related Image:

New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... to impossible, but a new study adds to a ... CT scans may help spot the beginnings of disease ... the greatest risk for lung cancer, 6 percent were ... and follow-up biopsies to confirm the diagnosis. CT scans ...

(Date:5/21/2013)... Sunnyvale, California (PRWEB) May 21, 2013 ... invites individuals who are grieving to remember and honor ... an Evening of Remembrance Memorial Service, Sunday, June 2, ... at Skyline Boulevard, San Mateo, CA 94402. , ... non-denominational, and includes a short program with music, readings ...

(Date:5/21/2013)... Calif. (PRWEB) May 21, 2013 Not ... a dual diagnosis of Borderline Personality Disorder (BPD) and ... is proving to be successful for the treatment of ... 1, Alina Gorgorian, Ph.D., clinical director of Clearview ... in Los Angeles, will provide attendees of the West ...

(Date:5/21/2013)... more likely than their normal-weight counterparts to repeatedly ... continuity of care and leads to more emergency ... The practice of "doctor shopping" among overweight patients ... the health care system, whether that be off-putting ... by providers, or improperly sized medical equipment and ...

(Date:5/21/2013)... N.C. An attack on glioblastoma brain tumor cells ... in an early study to establish the proper dose ... treatment, developed at Duke and tested in an ongoing ... cells have an abundance of receptors that work like ... the cells. , The investigational therapy, known as ...

Breaking Medicine News(10 mins):Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2 Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3 Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2 Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2 Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3 Health News:'Doctor shopping' by obese patients negatively affects health 2 Health News:'Doctor shopping' by obese patients negatively affects health 3 Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2

[0] Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer [0] Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California [0] Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD [0] 'Doctor shopping' by obese patients negatively affects health [0] Poliovirus vaccine trial shows early promise for recurrent glioblastoma

... makers debate what levels of ozone in the air are ... that the inhaled pollutant impairs the bodys first line of ... as bacteria. , While it has long been known ... pollution, is associated with increased cardiovascular and pulmonary hospitalizations and ...

... Programs in ... Need, BUDAPEST, Hungary, Sept. 29 With more ... each year, it has never,been more critical to increase ... the U.S.-Middle East Partnership for,Breast Cancer Awareness and Research, ...

... finds 123 deaths linked to the products since 1969 ... experts on Friday urged the federal Food and Drug ... and cold medicines for young children. , The recommendation, ... in children under 2, and antihistamines in those younger ...

... MCLEAN, Va., Sept. 28 Sunrise Senior Living,Inc. ... on the status of the independent,investigation being conducted ... Directors, provided an update on management,s Sarbanes-Oxley,Section 404 ... on legal,proceedings. Special Independent Committee Investigation ...

... a,statement by ADA President Kathleen Roth, DDS, on ... Bill: "The American Dental Association applauds the ... in legislation reauthorizing,the State Children,s Health Insurance Program. ... care that they need to enjoy good,oral health. ...

... Medical today announced a,partnership with leading breast care ... including breast care physicians from,Connecticut to California, will ... and availability of an innovative, non-surgical,treatment option for ... will host a gathering of these new Centers ...

Ozone shuts down early immune response in lungs and body Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries FDA Advisers Urge Ban on Cold Medicines for Young Children Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Management's Internal Control Review Efforts and on Legal Proceedings Statement by ADA President Kathleen Roth, DDS, on the Inclusion of Stable Dental Benefit in SCHIP Reauthorization Bill Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas

(Date:5/21/2013)... PARIS and TARRYTOWN, N.Y. ... and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) ... Medicine published online the positive Phase 2a study ... asthma. Dupilumab is an investigational monoclonal antibody targeting the ... which modulates signaling of both IL-4 and IL-13, drivers ...

(Date:5/21/2013)... U.S. spending on specialty prescription drugs — ... cancer, multiple sclerosis and rheumatoid arthritis — is projected ... according to a forecast released today by Express Scripts ... "As we see what,s on the ... act so they can continue to offer an affordable ...

(Date:5/21/2013)... , May 21, 2013 AcelRx ... a specialty pharmaceutical company focused on the ... the treatment of acute and breakthrough pain, ... a placebo-controlled Phase 3 study of its ... System (NanoTab System), the primary efficacy endpoint ...

Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7 U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2 U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3 U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4 U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9 Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10

[0] Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine [0] U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 [0] Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain

... Fla., Oct. 11, 2011 PediaVision announced today that ... United States to increase their efficiency and income through ... screening device that will help redefine the pediatric office ... pediatrics center in New Jersey, is a model of ...

... Heart disease is an ever-present threat in the family of ... experienced a heart attack in her early fifties. That,s why the ... Aspirin and WomenHeart: The National Coalition for Women with Heart ... Health to get women talking to each other and their ...

Cached Medicine Technology:Spot Helps Redefine the Pediatric Office of the Future 2 Spot Helps Redefine the Pediatric Office of the Future 3 Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers 2 Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers 3 Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers 4 Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers 5 Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers 6

Spot Helps Redefine the Pediatric Office of the Future Joy & Eve Behar Launch Bilingual Heart Health Guide Inspired By Women Heart Attack Survivors and Caregivers

... 105SL combines enhanced memory, processing ... and reliable all-metal construction. Proven ... and print speed make it ... who value reliability, productivity, consistent ...

... Built on the solid, tested ... six-inch labels --offers an unprecedented level ... placement as well as unique features ... into enterprise systems, automatic calibration, flexible ...

... The 220XiIII quickly prints labels ... at 10 ips. It is ... such as printing chemical drum ... automotive industry labels, banner-sized labels ...

... The 140XiIII is the fastest ... Series. With such powerful performance and ... choice for high-volume, mission-critical applications with ... also well-suited for applications in which ...

Medicine Products:

105SL R170Xi Zebra Printer 220xiIII Zebra 140xiIII Barcode Printer